PATENT CLAIM ANALYSIS

Application Number: 16319817
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["424", "001650"]

Abstract:
The present invention relates to novel compounds of the formula (II) that can be employed in the selective Tau detection of disorders and abnormalities associated with Tau aggregates such as Alzheimer's disease and other tauopathies using Positron Emission Tomography (PET) Imaging.

Claim (Index 31):
A method of collecting data for the diagnosis of a disorder associated with tau aggregates in a sample or a patient comprising:\n (a) bringing a sample or a specific body part or body area suspected to contain a tau aggregate into contact with a compound as defined in  claim 13 ; (b) allowing the compound to bind to the tau aggregate; (c) detecting the compound bound to the tau aggregate; and (d) optionally correlating the presence or absence of compound binding with the tau aggregate with the presence or absence of tau aggregate in the sample or specific body part or body area.

Metadata:
- Claim Count in Document: 52.0
- Percentile: 99.0
- Lexical Diversity: 1.14634
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15112672', '14740595', '14486040', '14930442', '15324141']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7225435121807963
- 35 USC 102 Novelty (BERT): 0.5493547098552708
- Combined Prediction Score: 0.7052246319482437
- Mean Citation Score: 333.0849740000001
- Max Citation Score: 446.5339
- Similarity Product: 278.3735861070156

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test